ORL inhibits angiogenesis (VEGF, MMP-9, and CXCR4/CXCL12) and fatty acid synthesis (ACLY, ACC, and FASN) genes and protein expression with the induction of apoptotic genes in different breast cancer cell lines [2] (Figure 12). Here, CXCL12 is linked to breast cancer.